ArticleFrontiers in psychology2025
Psychometric properties of the transgender identity stigma scale in Argentina.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Introduction: Transgender identity stigma (TIS) threatens the well-being of transgender and gender-diverse (TGD) individuals. To the best of our knowledge, there are no validated TIS measures developed for TGD individuals living in Argentina. The purpose of this study was to evaluate the psychometric properties of a TIS scale among a sample of TGD individuals living in Argentina. Methods: This study consisted of a secondary data analysis of the TransCITAR cohort study. Participants were 484 TGD individuals living in Buenos Aires, Argentina. Items from the HIV Stigma Index and the Everyday Discrimination Scale were combined and adapted to design the TIS scale. Item reduction analyses were carried out. Keyser-Meyer-Olkin (KMO) test of sampling adequacy and Bartlett's Test of Sphericity were examined to verify the factorability of the scale. Exploratory factor analyses (EFA) were conducted using a principal component method with promax rotation to identify the underlying factors of the scale. Results: The KMO value was 0.83 and the Bartlett's Test of Sphericity showed correlations between the variables (χ2 = 5,901.26, d.f. = 66, Conclusion: The TIS scale showed great internal consistency, reliability, and construct and criterion validity among TGD individuals living in Argentina, with applicability in both research and clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.